NRX Pharmaceuticals(NRXP)

Search documents
NRX Pharmaceuticals(NRXP) - 2020 Q3 - Quarterly Report
2020-11-16 21:55
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Delaware | 82 ...
NRX Pharmaceuticals(NRXP) - 2020 Q2 - Quarterly Report
2020-08-14 20:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | Delaware | 82-2844431 | | --- | --- | | (State or other jurisdiction of incorporation | (I.R.S. Employer Identification Number) | | or organization) | | | 2645 N. Federal Highway, Suite 230 | | | Delray Beach, FL | 33483 | For the transition peri ...
NRX Pharmaceuticals(NRXP) - 2020 Q1 - Quarterly Report
2020-05-15 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 82-2844431 ...
NRX Pharmaceuticals(NRXP) - 2019 Q4 - Annual Report
2020-03-30 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of in ...
NRX Pharmaceuticals(NRXP) - 2019 Q3 - Quarterly Report
2019-11-14 20:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 82-28444 ...
NRX Pharmaceuticals(NRXP) - 2019 Q2 - Quarterly Report
2019-08-14 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 82-2844431 ...
NRX Pharmaceuticals(NRXP) - 2019 Q1 - Quarterly Report
2019-05-15 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 82-2844431 (S ...
NRX Pharmaceuticals(NRXP) - 2018 Q4 - Annual Report
2019-03-15 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38302 BIG ROCK PARTNERS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 82-2844431 FORM 10-K | (State or ot ...